Minerva Neurosciences, Inc. (NERV)
$2.89-9.12%Close
SELLCRISIS · day 30
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $20M
- Beta
- -0.12
- P/E (TTM)
- -0.12
- Short % float
- 45.88%
- Days to cover
- 13.0
- SI change
- +0.6%
- 1W
- -12.95%
- 1M
- -30.36%
- vs SPY 1W
- -13.37%
- vs SPY 1M
- -32.42%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on NERV?
- LOPJLB’s latest quantitative signal on Minerva Neurosciences, Inc. (NERV) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is NERV in?
- Minerva Neurosciences, Inc. (NERV) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Minerva Neurosciences, Inc. (NERV) do?
- Minerva Neurosciences, Inc. functions as a biopharmaceutical firm in the clinical development stage, primarily dedicated to uncovering and bringing to market novel therapeutic options for disorders affecting the central nervous system. Its portfolio of experimental treatments notably features roluperidone, an investigational drug aimed at managing schizophrenia, alongside MIN-301, a soluble rec…